SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-21-017477
Filing Date
2021-04-02
Accepted
2021-04-02 15:39:22
Documents
14
Period of Report
2021-06-15

Document Format Files

Seq Description Document Type Size
1 PRE 14A pbyi-pre14a_20210615.htm PRE 14A 2475094
2 GRAPHIC gvzixwki0dxk000012.jpg GRAPHIC 1130
3 GRAPHIC gvzixwki0dxk000001.jpg GRAPHIC 21478
4 GRAPHIC gvzixwki0dxk000007.jpg GRAPHIC 3452
5 GRAPHIC gvzixwki0dxk000002.jpg GRAPHIC 45411
6 GRAPHIC gvzixwki0dxk000003.jpg GRAPHIC 21478
7 GRAPHIC gvzixwki0dxk000006.jpg GRAPHIC 45411
8 GRAPHIC gvzixwki0dxk000011.jpg GRAPHIC 1030
9 GRAPHIC gvzixwki0dxk000010.jpg GRAPHIC 3862
10 GRAPHIC gvzixwki0dxk000013.jpg GRAPHIC 938
11 GRAPHIC gvzixwki0dxk000004.jpg GRAPHIC 45411
12 GRAPHIC gvzixwki0dxk000009.jpg GRAPHIC 1059
13 GRAPHIC gvzixwki0dxk000008.jpg GRAPHIC 1059
14 GRAPHIC gvzixwki0dxk000005.jpg GRAPHIC 23371
  Complete submission text file 0001564590-21-017477.txt   2774381
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35703 | Film No.: 21801866
SIC: 2834 Pharmaceutical Preparations